15% Off
15% Off
marketed by NATCO PHARMA LTD
• 28CAP
₹5100.00
M.R.P.: ₹6000
15% Off
Inclusive of all taxes
Sutinat capsule is an antineoplastic agent that helps to treat pancreatic neuroendocrine tumours, metastatic renal cell carcinoma and gastrointestinal stromal tumour by binding/blocking a certain protein (tyrosine kinase) responsible for the growth of cancer and inhibit the growth of new blood vessels within the tumour. Take this medication as prescribed by your doctor at the advised dose and
Hypersensitivity to sutinat capsule..
Babies: It is not applicable.
Lactating mothers: Sutinat capsule is considered unsafe in lactating mothers as it may cause harm to the baby.
Pregnancy: Sutinat capsule is considered unsafe but prescribed in life-threatening conditions.
Consult your doctor before use of this medication.
Driving: Sutinat capsule is considered unsafe while driving as it may decrease alertness, affect your vision are make you sleepy or dizzy.
Avoid driving if these symptoms occur.
Alcohol: Consult your doctor before the use of this medication.
Kidney: The sutinat capsule is considered safe in kidney patients.
No dose adjustments are needed.
Liver: Sutinat capsule is used with caution in patients with severe liver disease.
Dose adjustment of sutinat may be needed.
No dose adjustment is recommended in patients with mild to moderate liver disease.
Consult your doctor before use of this medication..
Nausea Vomiting Weakness Rash Abdominal pain Indigestion Discoloration of skin Fatigue Fever Dry skin High blood pressure Diarrhea Constipation Painful blisters on hands and feet Stomatitis (Inflammation of the mouth) Hair discoloration Pain in extremity Back pain Headache .
Sutinat capsule is an antineoplastic agent that helps to treat pancreatic neuroendocrine tumours, metastatic renal cell carcinoma, and gastrointestinal stromal tumour by binding/blocking certain proteins responsible for cancer growth and inhibiting the growth of new blood vessels within the tumour..
If you miss a dose, take it as soon as possible.
If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily.
Don't double the dose to catch up with the missed dose..
• Sutinat capsule is used for the treatment of thyroid cancer.
• Take this medication with or without food as prescribed by your doctor at the same time daily.
• Drink plenty of fluids as this medication may cause diarrhoea and inform your doctor if this condition continues or if you find blood in your stools.
• Be careful while you are using sharp objects as this medication may affect healing time.
• Monitor your blood pressure regularly while taking this medication.
Inform your doctor if you notice very high blood pressure symptoms such as severe headache, confusion, problems with your eyesight, nausea, or vomiting.
• Monitoring of thyroid gland function is recommended while taking this medicine.
Inform your doctor if you notice symptoms of weight gain, dry skin, and hair.
• It may cause serious bleeding problems.
Inform your doctor if you get headaches, stomach pain or if you notice blood in your urine or stools.
• Inform your doctor about the consumption of sutinat capsules before going for a surgical procedure.
• Avoid taking this medicine if you are pregnant, planning to conceive or breastfeeding..
• Sutinat capsule + Bepridil: Concurrent use of these drugs may result in an increased risk of qt-interval prolongation. • Sutinat capsule + Colchicine: Concurrent use of these drugs may result in an increased colchicine plasma concentration and increased risk of toxicity. • Sutinat capsule + Posaconazole: Concurrent use of these drugs may result in an increase of sunitinib plasma concentration and increased risk of qt-interval prolongation. • Sutinat capsule + Abametapir: Concurrent use of these drugs may result in an increased exposure of cyp3a4 substrate. • Sutinat capsule + Amisulpride: Concurrent use of these drugs may result in an increased risk of serious ventricular arrhythmias. • Sutinat capsule + Atazanavir: Concurrent use of these drugs may result in an increase plasma concentration of sunitinib and its active metabolites. • Sutinat capsule + Proton pump inhibitors: Concurrent use of these drugs may result in reduction in sunitinib bioavailability. • Sutinat capsule + Lumefantrine: Concurrent use of these drugs may result in an increased risk of qt-interval prolongation and decreased plasma concentration of sunitinib with a potential decrease in efficacy..
100% Authentic
Easy Return